申请人:AMGEN INC.
公开号:US10736883B2
公开(公告)日:2020-08-11
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed.
式(I)和式(II)化合物、其药学上可接受的盐、前述任何化合物的立体异构体或其混合物是 APJ 受体的激动剂,可用于治疗心血管疾病和其他疾病。式(I)和式(II)化合物具有如下结构:(I);(II)。还要求得到中间体(V)。